期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 167, 期 1, 页码 139-141出版社
WILEY
DOI: 10.1111/bjh.12937
关键词
chronic myeloid leukaemia; efficacy; generic; imatinib mesylate